Sign up
Quantellect · Congress · Trade Detail
ZOOMZoom Technologies, Inc. (ZOOM) [OP] F IlINg S TATuS : New S ubhOlDINg O F : Rollover IRA D ESCRIPTION : call
DemocratHouse

Marie Newman bought Zoom Technologies, Inc. (ZOOM) [OP] F IlINg S TATuS : New S ubhOlDINg O F : Rollover IRA D ESCRIPTION : call (ZOOM)

Marie Newman (D-IL), a U.S. Representative, has disclosed 3 trades in Zoom Technologies, Inc. (ZOOM) [OP] F IlINg S TATuS : New S ubhOlDINg O F : Rollover IRA D ESCRIPTION : call (ZOOM) since 2021, 1 purchase and 2 sales, worth an estimated $24K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: Marie Newman bought $1,001 - $15,000 of Zoom Technologies, Inc. (ZOOM) [OP] F IlINg S TATuS : New S ubhOlDINg O F : Rollover IRA D ESCRIPTION : call (ZOOM) on January 4, 2021. Since that trade, ZOOM is up +0.00% against the S&P 500 up +112.48%, an outperformance of -112.48%.

Across these filings, Marie Newman has been a net seller of ZOOM (a buy-to-sell ratio of 0.50). The most recent disclosed ZOOM transaction shown was dated January 15, 2021. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

ZOOM trades
3
Disclosed Vol
$24K
Buys
1
33%
Sells
2
67%
Buy / Sell
0.50
ratio
First → Last
2021

Marie Newman's ZOOM trades vs the price

ZOOM is up +0.00% since Marie Newman bought on January 4, 2021, versus +112.48% for the S&P 500.

Performance since this trade

Price change since trade
+0.00%
S&P 500 change since trade
+112.48%
Outperformance vs S&P 500
-112.48%

All Marie Newman ZOOM trades

TradedTypeSizeReturnEst. profit
January 15, 2021SELL$1,001 - $15,000N/A
January 15, 2021SELL$1,001 - $15,000N/A
January 4, 2021BUY$1,001 - $15,000N/A

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Marie Newman & ZOOM trading FAQ

Is it legal for Marie Newman to trade Zoom Technologies, Inc. (ZOOM) [OP] F IlINg S TATuS : New S ubhOlDINg O F : Rollover IRA D ESCRIPTION : call (ZOOM) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Zoom Technologies, Inc. (ZOOM) [OP] F IlINg S TATuS : New S ubhOlDINg O F : Rollover IRA D ESCRIPTION : call (ZOOM), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Marie Newman buy ZOOM?

Marie Newman disclosed a purchase of $1,001 - $15,000 of Zoom Technologies, Inc. (ZOOM) [OP] F IlINg S TATuS : New S ubhOlDINg O F : Rollover IRA D ESCRIPTION : call (ZOOM) on January 4, 2021, according to public STOCK Act filings.

How has ZOOM performed since Marie Newman's trade?

Since Marie Newman bought ZOOM on January 4, 2021, the stock is up +0.00%, versus +112.48% for the S&P 500 over the same period, an outperformance of -112.48%.

How many times has Marie Newman traded ZOOM?

Marie Newman has disclosed 3 ZOOM trades since 2021 (1 purchase and 2 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional ZOOM trades?

Quantellect tracks every disclosed congressional trade in Zoom Technologies, Inc. (ZOOM) [OP] F IlINg S TATuS : New S ubhOlDINg O F : Rollover IRA D ESCRIPTION : call (ZOOM) on the Zoom Technologies, Inc. (ZOOM) [OP] F IlINg S TATuS : New S ubhOlDINg O F : Rollover IRA D ESCRIPTION : call congressional trading page, which aggregates filings across all members of Congress.

Marie Newman's ZOOM tradesAll congressional filings for Zoom Technologies, Inc. (ZOOM) [OP] F IlINg S TATuS : New S ubhOlDINg O F : Rollover IRA D ESCRIPTION : callMarie Newman's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.